Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (141-150 of 310) with videos related to

Pageof 31
Sort By:
Future Medicinal Chemistry|June 30, 2018
Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus speciesJoana M Andrade, Luísa Custódio, Alessandra Romagnoli, et al.
Plos Neglected Tropical Diseases|November 18, 2015
Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the CystsLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
Frontiers in Oncology|February 28, 2024
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case reportSerena Vita, Alessandra D'Abramo, Andrea Coppola, et al.
International Journal of Medical Microbiology : IJMM|June 1, 2019
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assayIvana Palucci, Basem Battah, Alessandro Salustri, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
World TB Day 2026: Scientific innovation across the tuberculosis continuum must now translate into global impactDelia Goletti, Bruno Bezerril Andrade, Hanif Esmail, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2021
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patientsAlessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
Frontiers in Immunology|February 11, 2020
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against <i>Mycobacterium tuberculosis</i>Ivana Palucci, Giuseppe Maulucci, Flavio De Maio, et al.
Journal of Translational Medicine|June 27, 2021
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infectionElisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, et al.
The Journal of Infectious Diseases|February 10, 2004
Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosisDelia Goletti, Stefania Carrara, Donatella Vincenti, et al.
Pageof 31

Showing results (141-150 of 310) with videos related to

Sort By:
Pageof 31
Future Medicinal Chemistry|June 30, 2018
Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus speciesJoana M Andrade, Luísa Custódio, Alessandra Romagnoli, et al.
Plos Neglected Tropical Diseases|November 18, 2015
Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the CystsLinda Petrone, Valentina Vanini, Elisa Petruccioli, et al.
Frontiers in Oncology|February 28, 2024
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case reportSerena Vita, Alessandra D'Abramo, Andrea Coppola, et al.
International Journal of Medical Microbiology : IJMM|June 1, 2019
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assayIvana Palucci, Basem Battah, Alessandro Salustri, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
World TB Day 2026: Scientific innovation across the tuberculosis continuum must now translate into global impactDelia Goletti, Bruno Bezerril Andrade, Hanif Esmail, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2021
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patientsAlessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
Frontiers in Immunology|February 11, 2020
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against <i>Mycobacterium tuberculosis</i>Ivana Palucci, Giuseppe Maulucci, Flavio De Maio, et al.
Journal of Translational Medicine|June 27, 2021
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infectionElisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, et al.
The Journal of Infectious Diseases|February 10, 2004
Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosisDelia Goletti, Stefania Carrara, Donatella Vincenti, et al.
Pageof 31